Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Syntaxin 4 Inhibitors

Syntaxin 4, a key player in vesicular transport and membrane fusion, is an integral component of the SNARE complex. Direct chemical inhibition of Syntaxin 4 is challenging due to its essential role in these fundamental cellular processes. However, targeting associated pathways and processes can offer an indirect approach to modulate its function. The compounds listed, such as Tetanus toxin, Botulinum toxins, and N-Ethylmaleimide, target aspects of the SNARE complex formation or function. Tetanus toxin and various types of Botulinum toxins cleave or interfere with SNARE proteins, potentially disrupting Syntaxin 4's role in vesicular docking and fusion. N-Ethylmaleimide's ability to modify sulfhydryl groups can inhibit SNARE complex formation, thereby impacting Syntaxin 4.

Other chemicals like Dynasore, Brefeldin A, and Monensin affect different aspects of vesicle formation, trafficking, and fusion. Dynasore's inhibition of dynamin and Brefeldin A's disruption of the Golgi apparatus can indirectly impact the vesicular transport processes involving Syntaxin 4. Similarly, Monensin's alteration of Golgi function can influence Syntaxin 4-mediated vesicle trafficking. Additionally, compounds that affect cytoskeletal dynamics, such as Latrunculin A and Jasplakinolide, can indirectly modulate Syntaxin 4's function. The cytoskeleton plays a critical role in vesicle transport, and altering actin dynamics can impact the processes in which Syntaxin 4 is involved.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

N-Ethylmaleimide

128-53-0sc-202719A
sc-202719
sc-202719B
sc-202719C
sc-202719D
1 g
5 g
25 g
100 g
250 g
$22.00
$69.00
$214.00
$796.00
$1918.00
19
(1)

NEM modifies sulfhydryl groups and can inhibit SNARE complex formation, potentially impacting Syntaxin 4 function.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$151.00
$609.00
75
(4)

While primarily a Rac1 inhibitor, NSC 23766 can affect cellular transport processes, potentially influencing Syntaxin 4 function indirectly.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Dynasore inhibits dynamin, a GTPase involved in vesicle scission, potentially affecting Syntaxin 4-mediated vesicle transport.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Brefeldin A disrupts the Golgi apparatus, potentially affecting the trafficking of vesicles where Syntaxin 4 is involved.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Monensin alters Golgi function and vesicle trafficking, which could indirectly influence Syntaxin 4 activity.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin inhibits N-linked glycosylation, potentially affecting protein trafficking and indirectly impacting Syntaxin 4 function.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, a PI3 kinase inhibitor, can affect vesicular trafficking pathways, potentially influencing Syntaxin 4's role in these processes.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$265.00
$815.00
36
(2)

Latrunculin A disrupts actin polymerization, which is crucial for vesicle transport, potentially affecting Syntaxin 4 function.

Jasplakinolide

102396-24-7sc-202191
sc-202191A
50 µg
100 µg
$184.00
$305.00
59
(1)

Jasplakinolide stabilizes actin filaments and can influence vesicle transport, potentially impacting Syntaxin 4's role in membrane fusion.